Anti-obesity phenotypic screening looking to increase OBR cell surface expression

Tae Hee Kim, Dong Hwa Choi, Virginie Vauthier, Julie Dam, Xiaolan Li, Yeon Ju Nam, Yoonae Ko, Ho Jeong Kwon, Sang Hoon Shin, Jonathan Cechetto, Veronica Soloveva, Ralf Jockers

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The leptin receptor, OBR, is involved in the regulation of whole-body energy homeostasis. Most obese people are resistant to leptin and do not respond to the hormone. The prevention and reversal of leptin resistance is one of the major current goals of obesity research. We showed previously that increased OBR cell surface expression concomitantly increases cellular leptin signaling and prevents obesity development in mice. Improvement of OBR cell surface expression can thus be considered as an interesting anti-obesity therapeutic strategy. To identify compounds that increase the surface expression of OBR, we developed a cell-based, phenotypic assay to perform a high-content screen (HCS) against a library of 50,000 chemical compounds. We identified 67 compounds that increased OBR cell surface expression with AC50 values in the low micromolar range and no effect on total OBR expression and cellular toxicity. Compounds were classified into 16 chemical clusters, of which 4 potentiated leptin-promoted signaling through the JAK2/STAT3 pathway. In conclusion, development of a robust phenotypic screening approach resulted in the discovery of four new scaffolds that demonstrate the desired biological activity and could constitute an original therapeutic solution against obesity and associated disorders.

Original languageEnglish
Pages (from-to)88-99
Number of pages12
JournalJournal of Biomolecular Screening
Volume19
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Leptin
Screening
Obesity
Cell signaling
Leptin Receptors
Chemical compounds
Scaffolds (biology)
Bioactivity
Libraries
Toxicity
Assays
Homeostasis
Hormones
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Biotechnology
  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery

Cite this

Kim, T. H., Choi, D. H., Vauthier, V., Dam, J., Li, X., Nam, Y. J., ... Jockers, R. (2014). Anti-obesity phenotypic screening looking to increase OBR cell surface expression. Journal of Biomolecular Screening, 19(1), 88-99. https://doi.org/10.1177/1087057113499185
Kim, Tae Hee ; Choi, Dong Hwa ; Vauthier, Virginie ; Dam, Julie ; Li, Xiaolan ; Nam, Yeon Ju ; Ko, Yoonae ; Kwon, Ho Jeong ; Shin, Sang Hoon ; Cechetto, Jonathan ; Soloveva, Veronica ; Jockers, Ralf. / Anti-obesity phenotypic screening looking to increase OBR cell surface expression. In: Journal of Biomolecular Screening. 2014 ; Vol. 19, No. 1. pp. 88-99.
@article{5e4360b777074c8988c5b0227fff6ce4,
title = "Anti-obesity phenotypic screening looking to increase OBR cell surface expression",
abstract = "The leptin receptor, OBR, is involved in the regulation of whole-body energy homeostasis. Most obese people are resistant to leptin and do not respond to the hormone. The prevention and reversal of leptin resistance is one of the major current goals of obesity research. We showed previously that increased OBR cell surface expression concomitantly increases cellular leptin signaling and prevents obesity development in mice. Improvement of OBR cell surface expression can thus be considered as an interesting anti-obesity therapeutic strategy. To identify compounds that increase the surface expression of OBR, we developed a cell-based, phenotypic assay to perform a high-content screen (HCS) against a library of 50,000 chemical compounds. We identified 67 compounds that increased OBR cell surface expression with AC50 values in the low micromolar range and no effect on total OBR expression and cellular toxicity. Compounds were classified into 16 chemical clusters, of which 4 potentiated leptin-promoted signaling through the JAK2/STAT3 pathway. In conclusion, development of a robust phenotypic screening approach resulted in the discovery of four new scaffolds that demonstrate the desired biological activity and could constitute an original therapeutic solution against obesity and associated disorders.",
author = "Kim, {Tae Hee} and Choi, {Dong Hwa} and Virginie Vauthier and Julie Dam and Xiaolan Li and Nam, {Yeon Ju} and Yoonae Ko and Kwon, {Ho Jeong} and Shin, {Sang Hoon} and Jonathan Cechetto and Veronica Soloveva and Ralf Jockers",
year = "2014",
month = "1",
day = "1",
doi = "10.1177/1087057113499185",
language = "English",
volume = "19",
pages = "88--99",
journal = "Journal of Biomolecular Screening",
issn = "1087-0571",
publisher = "SAGE Publications Inc.",
number = "1",

}

Kim, TH, Choi, DH, Vauthier, V, Dam, J, Li, X, Nam, YJ, Ko, Y, Kwon, HJ, Shin, SH, Cechetto, J, Soloveva, V & Jockers, R 2014, 'Anti-obesity phenotypic screening looking to increase OBR cell surface expression', Journal of Biomolecular Screening, vol. 19, no. 1, pp. 88-99. https://doi.org/10.1177/1087057113499185

Anti-obesity phenotypic screening looking to increase OBR cell surface expression. / Kim, Tae Hee; Choi, Dong Hwa; Vauthier, Virginie; Dam, Julie; Li, Xiaolan; Nam, Yeon Ju; Ko, Yoonae; Kwon, Ho Jeong; Shin, Sang Hoon; Cechetto, Jonathan; Soloveva, Veronica; Jockers, Ralf.

In: Journal of Biomolecular Screening, Vol. 19, No. 1, 01.01.2014, p. 88-99.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anti-obesity phenotypic screening looking to increase OBR cell surface expression

AU - Kim, Tae Hee

AU - Choi, Dong Hwa

AU - Vauthier, Virginie

AU - Dam, Julie

AU - Li, Xiaolan

AU - Nam, Yeon Ju

AU - Ko, Yoonae

AU - Kwon, Ho Jeong

AU - Shin, Sang Hoon

AU - Cechetto, Jonathan

AU - Soloveva, Veronica

AU - Jockers, Ralf

PY - 2014/1/1

Y1 - 2014/1/1

N2 - The leptin receptor, OBR, is involved in the regulation of whole-body energy homeostasis. Most obese people are resistant to leptin and do not respond to the hormone. The prevention and reversal of leptin resistance is one of the major current goals of obesity research. We showed previously that increased OBR cell surface expression concomitantly increases cellular leptin signaling and prevents obesity development in mice. Improvement of OBR cell surface expression can thus be considered as an interesting anti-obesity therapeutic strategy. To identify compounds that increase the surface expression of OBR, we developed a cell-based, phenotypic assay to perform a high-content screen (HCS) against a library of 50,000 chemical compounds. We identified 67 compounds that increased OBR cell surface expression with AC50 values in the low micromolar range and no effect on total OBR expression and cellular toxicity. Compounds were classified into 16 chemical clusters, of which 4 potentiated leptin-promoted signaling through the JAK2/STAT3 pathway. In conclusion, development of a robust phenotypic screening approach resulted in the discovery of four new scaffolds that demonstrate the desired biological activity and could constitute an original therapeutic solution against obesity and associated disorders.

AB - The leptin receptor, OBR, is involved in the regulation of whole-body energy homeostasis. Most obese people are resistant to leptin and do not respond to the hormone. The prevention and reversal of leptin resistance is one of the major current goals of obesity research. We showed previously that increased OBR cell surface expression concomitantly increases cellular leptin signaling and prevents obesity development in mice. Improvement of OBR cell surface expression can thus be considered as an interesting anti-obesity therapeutic strategy. To identify compounds that increase the surface expression of OBR, we developed a cell-based, phenotypic assay to perform a high-content screen (HCS) against a library of 50,000 chemical compounds. We identified 67 compounds that increased OBR cell surface expression with AC50 values in the low micromolar range and no effect on total OBR expression and cellular toxicity. Compounds were classified into 16 chemical clusters, of which 4 potentiated leptin-promoted signaling through the JAK2/STAT3 pathway. In conclusion, development of a robust phenotypic screening approach resulted in the discovery of four new scaffolds that demonstrate the desired biological activity and could constitute an original therapeutic solution against obesity and associated disorders.

UR - http://www.scopus.com/inward/record.url?scp=84890827857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890827857&partnerID=8YFLogxK

U2 - 10.1177/1087057113499185

DO - 10.1177/1087057113499185

M3 - Article

VL - 19

SP - 88

EP - 99

JO - Journal of Biomolecular Screening

JF - Journal of Biomolecular Screening

SN - 1087-0571

IS - 1

ER -